companydata.dkOLANDER CLINICAL CONSULTING K/S: Financial statements 2023
CVR: 35860177
OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,882,763 and a net result of DKK 1,883,012 compared with DKK 1,880,355 the year before. That is a decrease of 1.9% compared with the year before. Equity amounted to DKK 621,549. The solvency ratio was 66.6%.
- Gross Profit
- 1,882,763 kr.
- Profit/Loss
- 1,883,012 kr.
- Equity
- 621,549 kr.
- Total Assets
- 933,500 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.9 mio. | 1.9 mio. | 622 t. | 0 |
| 2022 | - | 1.9 mio. | 1.9 mio. | 621 t. | - |
| 2021 | - | 1.8 mio. | 1.8 mio. | 687 t. | - |
| 2020 | - | 1.5 mio. | 1.5 mio. | 461 t. | - |
| 2019 | - | 1.4 mio. | 1.4 mio. | 491 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OLANDER CLINICAL CONSULTING K/S has published its annual report for 2022. Gross profit came to DKK 1,919,291, and the net result was DKK 1,880,355.
About OLANDER CLINICAL CONSULTING K/S
OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.